S. Welch

发表

The pharmacological activity of anandamide, a putative endogenous cannabinoid, in mice.

P. Smith, R. Mechoulam, D. R. Compton, 1994, The Journal of pharmacology and experimental therapeutics.

In vivo pharmacological effects of dihydro-β-erythroidine, a nicotinic antagonist, in mice

M. Damaj, S. Welch, B. Martin, 2005, Psychopharmacology.

Differential Tolerance to FTY720-Induced Antinociception in Acute Thermal and Nerve Injury Mouse Pain Models: Role of Sphingosine-1-Phosphate Receptor Adaptation

D. Selley, A. Lichtman, J. Burston, 2018, The Journal of Pharmacology and Experimental Therapeutics.

Receptor reserve reflects differential intrinsic efficacy associated with opioid diastereomers

S. Welch, T. Rich, R. Carliss, 2009, Pharmacology Biochemistry and Behavior.

Modulation of opioids via protection of anandamide degradation by fatty acid amide hydrolase.

S. Welch, D. Stevens, V. L. Haller, 2008, European journal of pharmacology.

Enhancement of transdermal fentanyl and buprenorphine antinociception by transdermal delta9-tetrahydrocannabinol.

S. Welch, F. Smith, D. Cichewicz, 2005, European journal of pharmacology.

Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors

D. Selley, S. Welch, W. Dewey, 2002, Brain Research.

Comparison of the ability of opioid analgesics to increase endogenous opioid-like activity in the cerebrospinal fluid of rabbits.

S. Welch, B. Martin, E. Bowman, 1985, Life sciences.

Modulation of Oral Morphine Antinociceptive Tolerance and Naloxone-Precipitated Withdrawal Signs by Oral Δ9-Tetrahydrocannabinol

S. Welch, D. Cichewicz, 2003, Journal of Pharmacology and Experimental Therapeutics.

Synergy between Δ9-tetrahydrocannabinol and morphine in the arthritic rat

S. Welch, V. L. Haller, M. Cox, 2007 .

The hypothermic and antinociceptive effects of intrathecal injection of CGRP (8-37) in mice.

S. Welch, D. Dombrowski, F. Smith, 1994, Life sciences.

Decrease in efficacy and potency of nonsteroidal anti-inflammatory drugs by chronic delta(9)-tetrahydrocannabinol administration.

S. Welch, J. Huffman, Rene Anikwue, 2002, The Journal of pharmacology and experimental therapeutics.

Decrease in Efficacy and Potency of Nonsteroidal Anti- Inflammatory Drugs by Chronic -Tetrahydrocannabinol Administration

S. Welch, J. Huffman, Rene Anikwue, 2002 .

Reversal of Δ9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors

C. Bass, S. Welch, B. Martin, 2004 .

Characterization of Δ9-Tetrahydrocannabinol and Anandamide Antinociception in Nonarthritic and Arthritic Rats

J. Lowe, S. Welch, K. Fujimori, 1998, Pharmacology Biochemistry and Behavior.

Enhancement mu opioid antinociception by oral delta9-tetrahydrocannabinol: dose-response analysis and receptor identification.

S. Welch, F. Smith, D. Cichewicz, 1999, The Journal of pharmacology and experimental therapeutics.

Enhancement of m Opioid Antinociception by Oral D 9 -Tetrahydrocannabinol: Dose-Response Analysis and Receptor Identification 1

S. Welch, F. Smith, D. Cichewicz, 1999 .

Interaction of morphine with intrathecally administered calcium and calcium antagonists: evidence for supraspinal endogenous opioid mediation of intrathecal calcium-induced antinociception in mice.

S. Welch, W. Dewey, D. Brase, 1988, The Journal of pharmacology and experimental therapeutics.

Sphingosine lysolipids in the CNS: endogenous cannabinoid antagonists or a parallel pain modulatory system?

D. Selley, S. Welch, L. Sim-Selley, 2013, Life sciences.

Low dose combination of morphine and delta9-tetrahydrocannabinol circumvents antinociceptive tolerance and apparent desensitization of receptors.

D. Selley, Paul A. Smith, S. Welch, 2007, European journal of pharmacology.

Evaluation of cAMP involvement in cannabinoid-induced antinociception.

A. Lichtman, S. Welch, B. Martin, 1995, Life sciences.

Modulation of cannabinoid-induced antinociception after intracerebroventricular versus intrathecal administration to mice: possible mechanisms for interaction with morphine.

S. Welch, C. Thomas, G. Patrick, 1995, The Journal of pharmacology and experimental therapeutics.

Blockade of cannabinoid-induced antinociception by norbinaltorphimine, but not N,N-diallyl-tyrosine-Aib-phenylalanine-leucine, ICI 174,864 or naloxone in mice.

S. Welch, 1993, The Journal of pharmacology and experimental therapeutics.

Interaction of the cannabinoid and opioid systems in the modulation of nociception

S. Welch, 2009, International review of psychiatry.

The Role of Several Kinases in Mice Tolerant to Δ9-Tetrahydrocannabinol

S. Welch, D. Stevens, Matthew C Lee, 2003, Journal of Pharmacology and Experimental Therapeutics.

The Role of Several Kinases in Mice Tolerant to (cid:1) 9 Tetrahydrocannabinol

S. Welch, D. Stevens, Matthew C Lee, 2003 .

Involvement of dynorphin B in the antinociceptive effects of the cannabinoid CP55,940 in the spinal cord.

S. Welch, G. Pugh, D. J. Mason, 1997, The Journal of pharmacology and experimental therapeutics.

Dynorphin B and spinal analgesia: induction of antinociception by the cannabinoids CP55,940, Δ9-THC and anandamide 1 Published on the World Wide Web on 18 January 2000. 1

Michael L. Eads, S. Welch, Susan J Houser, 2000, Brain Research.

Characterization of anandamide- and fluoroanandamide-induced antinociception and cross-tolerance to delta 9-THC after intrathecal administration to mice: blockade of delta 9-THC-induced antinociception.

S. Welch, L. D. Dunlow, G. Patrick, 1995, The Journal of pharmacology and experimental therapeutics.

Inhibition of protein phosphatases alters the expression of morphine tolerance in mice.

S. Welch, M. A. Bernstein, 1998, European journal of pharmacology.

The antinociceptive effect of Δ9-tetrahydrocannabinol in the arthritic rat involves the CB2 cannabinoid receptor

S. Welch, V. L. Haller, M. Cox, 2007 .

The Enhancement of Morphine Antinociception in Mice by Δ9-Tetrahydrocannabinol

S. Welch, F. Smith, D. Cichewicz, 1998, Pharmacology Biochemistry and Behavior.

Antisense Oligodeoxynucleotides to the Kappa1 Receptor Enhance Δ9-THC–Induced Antinociceptive Tolerance

S. Welch, David W Rowen, J. P. Embrey, 1998, Pharmacology Biochemistry and Behavior.

Progress toward understanding the cannabinoid receptor and its second messenger systems.

S. Welch, B. Martin, M. Abood, 1994, Advances in pharmacology.

Antinociceptive activity of intrathecally administered cannabinoids alone, and in combination with morphine, in mice.

S. Welch, D. Stevens, 1992, The Journal of pharmacology and experimental therapeutics.

Antisense oligodeoxynucleotides to the κ-1 receptor block the antinociceptive effects of Δ9-THC in the spinal cord

S. Welch, M. Abood, G. Pugh, 1995, Brain Research.

Modulation of free intracellular calcium and cAMP by morphine and cannabinoids, alone and in combination in mouse brain and spinal cord synaptosomes

S. Welch, G. Pugh, Pam P. Bass, 1994, Pharmacology Biochemistry and Behavior.

The role of endogenous opioids in enhancing the antinociception produced by the combination of delta 9-tetrahydrocannabinol and morphine in the spinal cord.

P. Smith, S. Welch, D. Dombrowski, 1996, The Journal of pharmacology and experimental therapeutics.

Interactions between delta 9-tetrahydrocannabinol and kappa opioids in mice.

P. Smith, S. Welch, B. Martin, 1994, The Journal of pharmacology and experimental therapeutics.

Antinociceptive and lethal effects of intraventricularly administered barium and strontium: antagonism by atropine sulfate or naloxone hydrochlorine.

S. Welch, F. Vocci, W. Dewey, 1983, Life sciences.

The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat.

S. Welch, M. Cox, 2004, European journal of pharmacology.

Salmon calcitonin-induced modulation of free intracellular calcium

S. Welch, K. Olson, 1991, Pharmacology Biochemistry and Behavior.

The role of endogenous peptides in the action of opioid analgesics.

S. Welch, W. Dewey, M. Adams, 1986, Annals of emergency medicine.

The role of minoxidil on endogenous opioid peptides in the spinal cord: a putative co-agonist relationship between K-ATP openers and opioids.

S. Welch, V. C. Campbell, 2001, European journal of pharmacology.

Antinociceptive activity of intrathecally administered potassium channel openers and opioid agonists: a common mechanism of action?

S. Welch, L. D. Dunlow, 1993, The Journal of pharmacology and experimental therapeutics.

An investigation of the antinociceptive activity of calcitonin gene-related peptide alone and in combination with morphine: correlation to 45Ca++ uptake by synaptosomes.

S. Welch, W. Dewey, C. Cooper, 1988, The Journal of pharmacology and experimental therapeutics.

Synergistic interactions of endogenous opioids and cannabinoid systems

Michael L. Eads, S. Welch, 1999, Brain Research.

Morphine tolerance-induced modulation of [3H]glyburide binding to mouse brain and spinal cord.

S. Welch, W. Dewey, F. Smith, 1997, Drug and alcohol dependence.

Opiate tolerance-induced modulation of free intracellular calcium in synaptosomes.

S. Welch, K. Olson, 1991, Life sciences.

Calcitonin and Calcitonin Gene-Related Peptide

S. Welch, W. Dewey, 1989 .

Non-cannabinoid CB1, non-cannabinoid CB2 antinociceptive effects of several novel compounds in the PPQ stretch test in mice.

S. Welch, V. L. Haller, D. Cichewicz, 2006, European journal of pharmacology.

Characterization of anandamide-induced tolerance: comparison to delta 9-THC-induced interactions with dynorphinergic systems.

S. Welch, 1997, Drug and alcohol dependence.

A method for the determination of activated receptor phosphorylation state following in vivo drug treatment.

S. Welch, M. A. Bernstein, 1999, Brain research. Brain research protocols.

mu-Opioid receptor down-regulation and cAMP-dependent protein kinase phosphorylation in a mouse model of chronic morphine tolerance.

S. Welch, M. A. Bernstein, S. P. Welch, 1998, Brain research. Molecular brain research.

Modulation of free intracellular calcium levels [(Ca++)i] in brain and spinal cord of morphine-tolerant rats and mice

S. Welch, Pam P. Bass, 1995, Pharmacology Biochemistry and Behavior.

ATP-gated K(+) channel openers enhance opioid antinociception: indirect evidence for the release of endogenous opioid peptides.

S. Welch, A. B. Lohmann, 1999, European journal of pharmacology.

Antisenses to opioid receptors attenuate ATP-gated K(+) channel opener-induced antinociception.

S. Welch, A. B. Lohmann, 1999, European journal of pharmacology.

Nicotine-induced antinociception in mice: Role of G-proteins and adenylate cyclase

M. Damaj, S. Welch, B. Martin, 1994, Pharmacology Biochemistry and Behavior.

General Anesthesia : Intravenous and Inhalational Agents 291

M. Howie, S. Welch, W. Dewey, 2003 .

Changes in opioid and cannabinoid receptor protein following short-term combination treatment with delta(9)-tetrahydrocannabinol and morphine.

S. Welch, V. L. Haller, D. Cichewicz, 2001, The Journal of pharmacology and experimental therapeutics.

Synergy between delta9-tetrahydrocannabinol and morphine in the arthritic rat.

S. Welch, V. L. Haller, M. Cox, 2007, European journal of pharmacology.

The enhancement of morphine antinociception in mice by delta9-tetrahydrocannabinol.

S. Welch, F. Smith, D. Cichewicz, 1998, Pharmacology, biochemistry, and behavior.

Sphingosine‐1‐phosphate receptors mediate neuromodulatory functions in the CNS

S. Milstien, S. Spiegel, D. Selley, 2009, Journal of neurochemistry.

Differential blockade of the antinociceptive effects of centrally administered cannabinoids by SR141716A.

J. Lowe, S. Welch, J. Huffman, 1998, The Journal of pharmacology and experimental therapeutics.

Effects of spinal versus supraspinal administration of cyclic nucleotide-dependent protein kinase inhibitors on morphine tolerance in mice.

S. Welch, M. A. Bernstein, 1997, Drug and alcohol dependence.

Blockade of cannabinoid-induced antinociception by naloxone benzoylhydrazone (NalBZH)

S. Welch, 1994, Pharmacology Biochemistry and Behavior.

Involvement of calcium and L-type channels in nicotine-induced antinociception.

M. Damaj, S. Welch, B. Martin, 1993, The Journal of pharmacology and experimental therapeutics.

Decreased basal endogenous opioid levels in diabetic rodents: effects on morphine and delta-9-tetrahydrocannabinoid-induced antinociception.

S. Welch, D. Stevens, V. L. Haller, 2008, European journal of pharmacology.

Characterizationand Modulationof AcuteToleranceto Nicotinein Mice

M. Damaj, S. Welch, B. A. Martin, 2006 .

Comparative pharmacology of nicotine and ABT-418, a new nicotinic agonist

M. Aceto, M. Damaj, S. Welch, 1995, Psychopharmacology.

The role of gonadal hormones on opioid receptor protein density in arthritic rats.

S. Welch, V. L. Haller, M. Kren, 2008, European journal of pharmacology.

Mu and delta opioid-stimulated [35S]GTP gamma S binding in brain and spinal cord of polyarthritic rats.

D. Selley, S. Welch, L. Sim-Selley, 2004, European journal of pharmacology.

Morphine potentiates neurodegenerative effects of HIV-1 Tat through actions at μ-opioid receptor-expressing glia.

P. Knapp, S. Welch, N. El-Hage, 2011, Brain : a journal of neurology.

Sphingosine-1-phosphate receptors as emerging targets for treatment of pain.

D. Selley, S. Welch, L. Sim-Selley, 2012, Biochemical pharmacology.

Time course of the enhancement and restoration of the analgesic efficacy of codeine and morphine by delta9-tetrahydrocannabinol.

S. Welch, D. Stevens, V. L. Haller, 2006, European journal of pharmacology.

Cannabinoid modulation of dynorphin A: correlation to cannabinoid-induced antinociception.

J. Lowe, S. Welch, D. J. Mason, 1999, European journal of pharmacology.

Comparison of [(3)H]Glyburide binding with opiate analgesia, tolerance, and dependence in ICR and Swiss-Webster mice.

S. Welch, W. Dewey, V. C. Campbell, 2000, The Journal of pharmacology and experimental therapeutics.

Antinociceptive activity of salmon calcitonin injected intraventricularly in mice: modulation of morphine antinociception.

S. Welch, W. Dewey, C. Cooper, 1986, The Journal of pharmacology and experimental therapeutics.

The antinociception produced by intrathecal morphine, calcium, A23187, U50,488H, [D-Ala2, N-Me-Phe4, Gly-ol]enkephalin and [D-Pen2, D-Pen5]enkephalin after intrathecal administration of calcitonin gene-related peptide in mice.

S. Welch, W. Dewey, A. Singha, 1989, The Journal of pharmacology and experimental therapeutics.

Further studies on the antinociceptive effects ofΔ acid

S. Welch, S. Doyle, W. Dewey, 1990, Agents and Actions.

Morphine-induced modulation of calcitonin gene-related peptide levels

S. Welch, K. Olson, G. Pugh, 1992, Pharmacology Biochemistry and Behavior.

Alterations in L-type calcium channels in the brain and spinal cord of acutely treated and morphine-tolerant mice

S. Welch, M. A. Bernstein, 1995, Brain Research.

Chronic morphine treatment decreases the Cav1.3 subunit of the L-type calcium channel.

S. Welch, V. L. Haller, M. A. Bernstein, 2008, European journal of pharmacology.

Differential effects of divalent cations, cation chelators and an ionophore (A23187) on morphine and dibutyryl guanosine 3': 5'-cyclic monophosphate antinociception.

S. Welch, F. Vocci, W. Dewey, 1980, The Journal of pharmacology and experimental therapeutics.

The effects of dynorphin A (1-13) and U50, 488H on free intracellular calcium in guinea pig cerebellar synaptosomes.

S. Welch, K. Olson, 1991, Life sciences.

A proposed mechanism of action for the antinociceptive effect of intrathecally administered calcium in the mouse.

S. Welch, W. Dewey, D. Stevens, 1992, The Journal of pharmacology and experimental therapeutics.

The appearance of endogenous opiates in cerebrospinal fluid following opiate injection in various animal species.

S. Welch, B. Martin, E. Bowman, 1982, Life sciences.

Characterization and modulation of acute tolerance to nicotine in mice.

M. Damaj, S. Welch, B. Martin, 1996, The Journal of pharmacology and experimental therapeutics.

Opioid and Nonopioid Analgesics

S. Welch, B. Martin, 2003 .

Reversal of delta 9-tetrahydrocannabinol-induced tolerance by specific kinase inhibitors.

C. Bass, S. Welch, B. Martin, 2004, European Journal of Pharmacology.

The antinociceptive effect of Delta9-tetrahydrocannabinol in the arthritic rat involves the CB(2) cannabinoid receptor.

S. Welch, V. L. Haller, M. Cox, 2007, European journal of pharmacology.

Antinociceptive activity of intrathecal ketorolac is blocked by the kappa-opioid receptor antagonist, nor-binaltorphimine.

E. Ellis, S. Welch, C. Ward, 1993, European journal of pharmacology.

Blockade of the antinociceptive activity of centrally administered ketorolac by nor-binaltorphimine.

S. Welch, A. Tripathi, 1995, European journal of pharmacology.

The mouse paw withdrawal assay: a method for determining the effect of calcitonin gene-related peptide on cutaneous heat nociceptive latency time.

S. Welch, W. Dewey, M. Saxen, 1993, Life sciences.